整合素αM
髓样
肿瘤微环境
癌症研究
免疫系统
生物
车站3
祖细胞
细胞因子
细胞生物学
化学
免疫学
信号转导
干细胞
作者
Jianmin Zhu,Jianyu Yu,Aiyan Hu,Jin-Qing Liu,Xueliang Pan,Gang Xin,William E. Carson,Zihai Li,Yiping Yang,Xue‐Feng Bai
出处
期刊:Journal of Immunology
[American Association of Immunologists]
日期:2023-07-17
卷期号:211 (5): 895-902
被引量:11
标识
DOI:10.4049/jimmunol.2300176
摘要
IL-27 is a pleiotropic cytokine that exhibits stimulatory/regulatory functions on multiple lineages of immune cells and has a potential to be used as a therapeutic for cancer. We have recently demonstrated that administration of IL-27 producing adeno-associated virus (AAV-IL-27) exhibits potent inhibition of tumor growth in mouse models. In this study, we demonstrate that AAV-IL-27 treatment leads to significant expansion of CD11b+Gr1+ myeloid cells. AAV-IL-27-induced expansion of CD11b+Gr1+ cells is IL-27R-dependent and requires Stat3 signaling, but it is inhibited by Stat1 signaling. AAV-IL-27 treatment does not increase the self-renewal capacity of CD11b+Gr1+ cells but induces significant expansion of Lin-Sca1+c-Kit+ (LSK) and granulocyte-monocyte progenitor cells. Despite exhibiting significant suppression of T cells in vitro, IL-27-induced CD11b+Gr1+ cells lost the tumor-promoting activity in vivo and overall play an antitumor role. In tumors from AAV-IL-27-treated mice, CD11b+Gr1+ cells are largely F4/80+ and express high levels of MHC class I/II and M1 macrophage markers. Thus, IL-27 gene therapy induces Stat3-mediated expansion of CD11b+Gr1+ myeloid cells and promotes accumulation of M1 macrophages in the tumor microenvironment.
科研通智能强力驱动
Strongly Powered by AbleSci AI